Discovery & Development

Adcendo signs antibody drug conjugate licensing deal with DualityBio.

The world needs new medicines to treat obesity-related conditions. Here’s what researchers at the UK’s University of Birmingham are doing about it.

Improved mutational understanding may help develop therapeutics against antimicrobial resistance

We interviewed Gamma Biosciences’s CTO Phil Vanek to learn more about the current state of the Cell and Gene Industry

Investment into new antimicrobial therapies has been lacking for decades – and now we’re now paying the price.

Swedish researchers target the brain’s reward system to treat alcohol use disorder

The science behind space-based medicine is a bit of a slow-burner, but it’s on the launchpad

We had the pleasure of video interviewing Vered Caplan, CEO of Orgenesis, at the latest ISCT convention in Paris (2023).

Check out our latest video interview with Angela Osborne who discusses the latest cell and gene industry trends.

Researchers have designed a “mini gene” therapy that could hold promise for treating Usher Syndrome Type 1F